Abstract
Mesial temporal lobe epilepsy (mTLE) is a common localization of drug-resistant epilepsy in adults. Patients often undergo intracranial EEG (iEEG) monitoring to confirm localization and determine candidacy for focal ablation or resection. Clinicians primarily base surgical decision-making on seizure onset patterns, with imaging abnormalities and information from interictal epileptiform discharge (spikes) used as ancillary data. How the morphology and timing of spikes within multi-electrode sequences may inform surgical planning is unknown, in part due to the lack of measurement methods for large datasets. We hypothesized that patients with mTLE have a distinct mesial-to-lateral spike pattern that differentiates them from other epilepsy localizations. In a multicenter study at the University of Pennsylvania and the Medical University of South Carolina, we analyzed the timing and morphology of spikes and seizure high frequency energy ratio (HFER) in 75 patients with drug-resistant epilepsy. We compared these features across patients with mTLE, temporal neocortical epilepsy, and other localizations. A logistic regression model combining all features predicted a clinical localization of mTLE in unseen patients with an AUC of 0.82 (compared to an AUC of 0.70 for seizure-only features, DeLong’s test p = 0.08). Spike rate was the most important feature in the combined model. Modeled probability of mTLE was similar between patients who had a good versus a poor 12-month outcome after undergoing a mesial temporal resection or ablation (p = 0.34). These findings support quantitative spike analysis to supplement analysis of seizures for use in surgical planning.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
C.A.A received support form the National Science Foundation Research Grant Fellowship (DGE-2236662). E.C.C. and J.K received support from the National Institute of Neurological Disorders and Stroke (NINDS K23 NS121401-01A1) and the Burroughs Wellcome Fund. W.K.S.O. was supported by the National Science Foundation Research Grant Fellowship (DGE-1845298). J.J.L. was supported by the National Institute of Neurological Disorders and Stroke (5T32NS091006-08). E.G. received support from Georgia Clinical and Translational Science Awards UL1 (UL1TR002378) and KL2 (KL2TR002381) grants. K.A.D. and A.L received support from the National Institute of Neurological Disorders and Stroke (NIH; R01 NS116504, R01 NS125137, R61 NS125568). C.A.E. was supported by the National Institute of Neurological Disorders and Stroke of the National Institutes of Health Award Number K23NS121520. B.L, S.L, and A.R.P are funded by the National Institute of Neurological Disorders and Stroke DP1NS122038; by the National Institutes of Health R01NS125137; the Mirowski Family Foundation; by contributions from Neil and Barbara Smit; and by contributions from Jonathan and Bonnie Rothberg.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
All data is publicly available on ieeg.org
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability Statement
Github repository will be released with code to replicate all analysis reported in the study. All data tables will be available for download.
